HoldThatWinner (31.10)

Sectors With The Most Picks

Biotechnology

Outperform
Ticker Company Name Pick Date Score
View all Tickers in Tag
FOLD Amicus Therapeutics, Inc. 6/17/2013 +130.97
INCY Incyte Corp 8/21/2013 +76.88
VICL Vical, Inc. 9/27/2010 +70.31
RNA Prosena Holding 9/24/2013 +62.85
CHTP Chelsea Therapeutics International Ltd. 2/20/2013 +44.77
EXAS EXACT Sciences Corp 4/18/2013 +37.76
SRPT Sarepta Therapeutics Inc 11/12/2012 +19.18
PBYI Puma Biotechnology Inc. 7/24/2014 +18.39
ITMN InterMune, Inc. 3/14/2011 +18.35
THLD Threshold Pharmaceuticals, Inc. 3/28/2013 +17.87
PRAN Prana Biotechnology Limited (ADR) 5/12/2014 +15.07
CYTX Cytori Therapeutics, Inc. (USA) 9/6/2011 +14.34
AFFY Affymax Inc Com 10/8/2010 +13.55
DNDN Dendreon Corp 10/3/2011 +11.11
PPHM Peregrine Pharmaceuticals 9/27/2012 +11.09
ARNA Arena Pharmaceuticals, Inc. 9/14/2010 +9.71
CBLI Cleveland BioLabs, Inc. 11/9/2012 +8.99
CRIS Curis, Inc. 10/1/2010 +8.81
CYCC Cyclacel Pharmaceuticals Inc 9/20/2012 +8.62
DNDN Dendreon Corp 11/4/2011 +8.29
CLVS Clovis Oncology 3/25/2013 +7.59
QCOR Questcor Pharmaceuticals 11/25/2011 +7.22
AFFY Affymax Inc Com 3/28/2012 +7.19
PIP PharmAthene, Inc. 4/17/2013 +6.99
SQNM Sequenom, Inc. 8/14/2012 +6.21
ARNA Arena Pharmaceuticals, Inc. 8/31/2010 +5.23
CLDX Celldex Therapeutics, Inc. 5/15/2014 +4.89
ANIP Ani Pharmaceuticals, Inc. 8/14/2012 +4.36
INCY Incyte Corp 9/29/2010 +3.99
ONCY Oncolytics Biotech, Inc. (USA) 9/23/2010 +0.65
ECYT Endocyte, Inc. 5/2/2014 -16.26
VICL Vical, Inc. 9/3/2013 -20.94
CLVS Clovis Oncology 6/5/2013 -41.90
PPHM Peregrine Pharmaceuticals 2/13/2013 -43.37
GTXI GTx, Inc. 8/20/2013 -64.58
MNKD MannKind Corp 11/12/2010 -65.57
CYTX Cytori Therapeutics, Inc. (USA) 8/6/2014 -71.22
CLSN Celsion Corporation 2/4/2013 -77.65
RIGL Rigel Pharmaceuticals, Inc. 4/5/2013 -88.63
AFFY Affymax Inc Com 3/5/2013 -117.37
SVNTQ Savient Pharmaceuticals Inc Com 3/28/2012 -134.78
WGBSD Wafergen Bio-systems Inc Com 9/20/2010 -135.73
Underperform
Ticker Company Name Pick Date Score
View all Tickers in Tag
TEAR OccuLogix, Inc. (USA) 3/22/2013 +78.22
RXII RXi Pharmaceuticals Corporation 3/21/2012 +41.98
INFI Infinity Pharmaceuticals, Inc. 6/17/2013 +37.53
OSIR Osiris Therapeutics, Inc. 8/14/2013 +36.81
CLDX Celldex Therapeutics, Inc. 10/5/2010 +32.41
AEZS Aeterna Zentaris Inc 4/5/2013 +28.59
MYGN Crescendo Bioscience, Inc. 6/17/2013 +27.52
THLD Threshold Pharmaceuticals, Inc. 2/24/2012 +25.17
QCOR Questcor Pharmaceuticals 8/14/2012 +20.65
ECYT Endocyte, Inc. 9/28/2012 +16.19
CLVS Clovis Oncology 11/12/2012 +15.75
NVGN Novogen Limited (ADR) 4/3/2013 +15.73
PIP PharmAthene, Inc. 11/16/2010 +15.27
SRPT Sarepta Therapeutics Inc 4/3/2013 +14.90
VVUS VIVUS, Inc. 2/23/2012 +14.39
KERX Keryx Biopharmaceuticals 1/29/2013 +14.12
ALXN Alexion Pharmaceuticals, Inc. 10/19/2012 +11.79
JAZZ Jazz Pharmaceuticals, Inc. 2/24/2012 +11.53
PCYC Pharmacyclics, Inc. 10/22/2012 +11.03
VRTX Vertex Pharmaceuticals, Inc. 4/19/2013 +10.74
THLD Threshold Pharmaceuticals, Inc. 3/20/2012 +10.46
IMUC ImmunoCellular Therapeutics, Ltd. 3/1/2012 +10.22
ACHN Achillion Pharmaceuticals, Inc. 10/19/2012 +9.84
CHTP Chelsea Therapeutics International Ltd. 9/20/2010 +9.32
AFFY Affymax Inc Com 10/19/2012 +8.99
ACAD ACADIA Pharmaceuticals, Inc. 3/21/2013 +8.98
STEM StemCells, Inc. 2/12/2013 +8.82
GWPH GW Pharmaceuticals plc 7/10/2014 +8.81
ONTY Oncothyreon, Inc. 12/19/2012 +8.56
SRPT Sarepta Therapeutics Inc 5/2/2013 +8.45
ECYT Endocyte, Inc. 1/31/2013 +8.15
REGN Regeneron Pharmaceuticals, Inc. 2/16/2012 +7.73
SGEN Seattle Genetics, Inc. 5/28/2013 +7.67
CBST Cubist Pharmaceuticals, Inc. 3/8/2013 +7.13
ZIOP ZIOPHARM Oncology 10/19/2012 +6.97
PCYC Pharmacyclics, Inc. 3/25/2013 +6.32
NVGN Novogen Limited (ADR) 2/19/2013 +5.93
SGEN Seattle Genetics, Inc. 9/27/2010 +5.83
JAZZ Jazz Pharmaceuticals, Inc. 3/28/2012 +5.24
EXAS EXACT Sciences Corp 9/27/2010 +3.77
RTRX Retrophin, Inc. 6/6/2014 +3.70
GERN Geron Corp 9/13/2010 +3.18
ITMN InterMune, Inc. 10/7/2010 +2.54
ANTH Anthera Pharmaceuticals Inc 9/24/2010 +2.37
QCOR Questcor Pharmaceuticals 9/9/2010 +0.49
MON Monsanto Company 8/14/2012 -0.27
JNJ Johnson & Johnson 5/23/2013 -2.47
PCYC Pharmacyclics, Inc. 6/13/2013 -12.91
PTCT PTC Therapeutics 5/27/2014 -86.06
ACAD ACADIA Pharmaceuticals, Inc. 4/11/2013 -106.95
MDVN Medivation, Inc. 2/28/2012 -144.82
QCOR Questcor Pharmaceuticals 9/24/2012 -350.25

Dedicated Short Bias Funds

 
21 Outperform
 
53 Underperform

Metals and Mining

 
47 Outperform
 
21 Underperform

Oil, Gas and Consumable Fuels

 
25 Outperform
 
18 Underperform

Semiconductors and Semiconductor Equipment

 
12 Outperform
 
12 Underperform

Pharmaceuticals

 
5 Outperform
 
18 Underperform

Internet Software and Services

 
15 Outperform
 
8 Underperform

Hotels, Restaurants and Leisure

 
8 Outperform
 
13 Underperform

Diversified Financial Services

 
7 Outperform
 
12 Underperform

Software

 
10 Outperform
 
8 Underperform

Electrical Equipment

 
11 Outperform
 
7 Underperform

Machinery

 
9 Outperform
 
8 Underperform

Household Durables

 
4 Outperform
 
13 Underperform

Food Products

 
9 Outperform
 
7 Underperform

Specialty/Miscellaneous Funds

 
5 Outperform
 
8 Underperform

Specialty Retail

 
2 Outperform
 
11 Underperform

Media

 
3 Outperform
 
8 Underperform

Energy Equipment and Services

 
6 Outperform
 
4 Underperform

Financial Services Funds

 
5 Outperform
 
4 Underperform

Internet and Catalog Retail

 
2 Outperform
 
7 Underperform

Diversified Consumer Services

 
6 Outperform
 
3 Underperform

Communications Equipment

 
4 Outperform
 
5 Underperform

Chemicals

 
3 Outperform
 
6 Underperform

Computers and Peripherals

 
3 Outperform
 
5 Underperform

Road and Rail

 
1 Outperform
 
5 Underperform

Personal Products

 
0 Outperform
 
5 Underperform

Beverages

 
3 Outperform
 
2 Underperform

Leisure Equipment and Products

 
2 Outperform
 
3 Underperform

Diversified Leverage Funds

 
1 Outperform
 
3 Underperform

Life Sciences Tools and Services

 
1 Outperform
 
3 Underperform

Electronic Equipment, Instruments and Components

 
2 Outperform
 
2 Underperform

Capital Markets

 
3 Outperform
 
1 Underperform

Natural Resources Funds

 
1 Outperform
 
3 Underperform

Healthcare Equipment and Supplies

 
2 Outperform
 
2 Underperform

Food and Staples Retailing

 
2 Outperform
 
1 Underperform

Automobiles

 
0 Outperform
 
3 Underperform

Gold Oriented Funds

 
1 Outperform
 
1 Underperform

Diversified Telecommunication Services

 
1 Outperform
 
1 Underperform

Health/Biotechnology Funds

 
0 Outperform
 
1 Underperform

Tobacco

 
1 Outperform
 
0 Underperform

Real Estate Management and Development

 
1 Outperform
 
0 Underperform

Paper and Forest Products

 
0 Outperform
 
1 Underperform

Office Electronics

 
0 Outperform
 
1 Underperform

Transportation Infrastructure

 
0 Outperform
 
1 Underperform

Consumer Services Funds

 
0 Outperform
 
1 Underperform

Featured Broker Partners


Advertisement